Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

Investment analysts at William Blair dropped their Q1 2025 earnings estimates for shares of Abbott Laboratories in a report ...

Dec. 13, 2024 — Influenza or flu virus remains infectious in refrigerated raw milk for up to five days, according to a new study. The findings come at a time when outbreaks of bird flu -- a ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by Wells Fargo & Company from $133.00 to $136 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Stay connected with Abbott for news, educational resources and innovations in the field of diagnostics.

Earnings Report 1.110 USD Q4 2021 Earnings Release 01/26/2022 Indices Commodities Currencies Stocks ...